ANDA 62289, held by King Pharms. Gentamicin Sulfate.
As of Nov 15, 2026, ANDA 62289 (Apogen), held by King Pharms, was not approved, with 0 approved supplements and 0 published complete response letters.
| ApogenEQ 10MG BASE/ML · injectable;injection | Gentamicin Sulfate | Discontinued |
| ApogenEQ 40MG BASE/ML · injectable;injection | Gentamicin Sulfate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
